The Relationship between Functional Status and Inflammatory Disease in Older Adults

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 58, Issue 11, 2003, Pages 995-998

  Thomas, David R ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MEGESTROL ACETATE; TESTOSTERONE;

AGED; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; CYTOKINE PRODUCTION; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG EFFECT; EDITORIAL; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; MORBIDITY; MORTALITY; PHENOTYPE; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; QUALITY OF LIFE; RISK ASSESSMENT; TRAINING;

EID: 0344153763     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/58.11.m995     Document Type: Editorial

References (66)

1. Thomas DR. Focus on functional decline in hospitalized older adults. J Gerontol Med Sci. 2002;57A:M567-M568.
2. Fortinsky RH, Covinsky KE, Palmer RM, Landefeld CS. Effects of functional status changes before and during hospitalization on nursing home admission of older patients. J Gerontol Med Sci. 1999;54A: M521-M526.
3. Foley DJ, Ostfeld AM, Branch LG, Wallace RB, McGloin J, Comoni-Huntley JC. The risk of nursing home admission in three communities. J Aging Health. 1992;4:155-173.
4. Fried LP, Bush TL. Morbidity as a focus of preventive health care in the elderly. Epidemiol Rev. 1988;10:48-64.
5. Thomas DR. The critical link between health-related quality of life and age-related changes in physical activity and nutrition. J Gerontol Med Sci. 2001;56A:M599-M602.
6. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231-243.
7. Morley JE. Anorexia, sarcopenia, and aging, Nutrition. 2001;17:660-663.
8. Morley JE. Sarcopenia revisited. J Gerontol Med Sci. 2003;58A:909-910.
9. Marcell TJ. Sarcopenia: causes, consequences and preventions. J Gerontol Med Sci. 2003;58A:911-916.
10. Morley JE, Perry HM, Miller DK. Something about frailty. J Gerontol Med Sci. 2002;57A:M698-M704.
11. Morley JE. Mobility performance: a high-tech test for geriatricians. J Gerontol Med Sci. 2003;58A:712-714.
12. Newman AB, Haggerty CL, Kritchevsky SB, Nevitt MC, Simonsick EM, for the Health ABC Collaborative Research Group. Walking performance and cardiovascular response: associations with age and morbidity-the health, aging and body composition study. J Gerontol Med Sci. 2003;58A:715-720.
13. Lan TY, Deeg DJH, Guralnik JM, Melzer D. Responsiveness of the index of mobility limitation: comparison with gait speed alone in the longitudinal aging study Amsterdam. J Gerontol Med Sci. 2003;58A: 721-727.
14. Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Luigi F. A comparison of leg power and leg strength within the InCHIANTI study: which influences mobility more? J Gerontol Med Sci. 2003;58A: 728-733.
15. Alexander NB, Dengel DR, Olson RJ, Krajewski JM. Oxygen-uptake (VO-2) kinetics and functional mobility performance in impaired older adults. J Gerontol Med Sci. 2003;58A:734-739.
16. Brandon LJ, Gaasch DA, Boyette LW, Lloyd AM. Effects of long-term resistive training on mobility and strength in older adults with diabetes. J Gerontol Med Sci. 2003;58A:740-745.
17. Thomas VS, Hageman PA. Can neuromuscular strength and function in people with dementia be rehabilitated using resistance-exercise training? Results from a preliminary intervention study. J Gerontol Med Sci. 2003;58A:746-751.
18. Gardner EM, Murasko DM. Age-related changes in type 1 and type 2 cytokine production in humans. Biogerontol. 2002;3:271-290.
19. Beharka AA, Meydani M, Wu DY, Leka LS, Meydani A, Meydani SN. Interleukin-6 production does not increase with age. J Gerontol Biol Sci. 2001;56A:B81-B88.
20. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol Med Sci. 1997;52A:M201-M208.
21. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women. The health ABC study. J Gerontol Med Sci. 2002;57A:M326-M332.
22. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med. 2003;114:180-187.
23. Reuben DB, Ferrucci L, Wallace R, et al. The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels. J Am Geriatr Soc. 2000;48:1404-1407.
24. Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102:3060-3067.
25. Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003;107:1486-1491.
26. Banks WA, Farr SA, La Scola ME, Morley JE. Intravenous human interleukin-1 alpha impairs memory processing in mice: dependence of blood-brain barrier transport in posterior division of the septum. J Pharmacol Exper Ther. 2001;299:536-541.
27. Banks WA, Morley JE. Memories are made of this: recent advances in understanding cognitive impairments and dementia. J Gerontol Med Sci. 2003;58A:314-321.
28. Chan DC, Kasper JD, Black BS, Rabins PV. Presence of behavioral and psychological symptoms predicts nursing home placement in community-dwelling elders with cognitive impairment in univariate but not multivariate analysis. J Gerontol Med Sci. 2003;58:548-554.
29. Sands LP, Yaffe K, Covinsky K, et al. Cognitive screening predicts magnitude of functional recovery from admission to 3 months after discharge in hospitalized elders. J Gerontol Med Sci. 2003;58A:37-45.
30. Blaum CS, Ofstedal MB, Liang J. Low cognitive performance, comorbid disease, and task-specific disability: findings from a nationally representative survey. J Gerontol Med Sci. 2002;57A:M523-M531.
31. Njegovan V, Man-Son-Hing M, Mitchell SL, Molnar FJ. The hierarchy of functional loss associated with cognitive decline in older persons. J Gerontol Med Sci. 2001;56A:M638-M643.
32. Royall DR, Chiodo LK, Polk MJ. Correlates of disability among elderly retirees with "subclinical" cognitive impairment. J Gerontol Med Sci. 2000;55A:541-546.
33. Hung AM, Chertow GM, Young BS, Carey S, Johansen KL. Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis. J Renal Nutr. 2002;12:170-176.
34. Shike M, Russell DM, Detsky AS, et al. Changes in body composition in patients with small-cell cancer. The effect of total parenteral nutrition as an adjunct to chemotherapy. Ann Int Med. 1984;101:303-309.
35. Mitch WE. Mechanisms causing loss of lean body mass in kidney disease. Am J Clin Nutr. 1998;67:359-366.
36. Hedlund J, Hansson LO, Ortqvist A. Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand J Infect Dis. 1995;27:32-37.
37. Toth MJ, Gottlieb SS, Goran MI, Fisher ML, Poehlman ET. Daily energy expenditure in free-living heart failure patients. Am J Physiol. 1997;272:469-475.
38. Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994;93:2379-2386.
39. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nurs. 1985;42:1255-1265.
40. Baez-Franceschi D, Morley JE. Physiopathology of the catabolism associated with malnutrition in the elderly. Zeitschrift fur Gerontologie und Geriatrie. 1999;32:12-19.
41. Thomas DR. Distinguishing starvation from cachexia. Clin Geriatr Med. 2002;18:883-891.
42. Thomas DR. Dietary prescription for chronic obstructive pulmonary disease. Clin Geriatr Med. 2002;18:835-839.
43. Ershler WB. Biological interactions of aging and anemia: a focus on cytokines. J Am Geriatr Soc. 2003;51:S18-S21.
44. Wilkinson TJ, Warren MR. What is the prognosis of mild normocytic anemia in older people? Int Med J. 2003;33:14-17.
45. Moritani T, DeVires H. Potential for gross muscle hypertrophy in older men. J Gerontol. 1980;35:672-682.
46. Brown AB, McCartney N, Sale DG. Positive adaptations to weightlifting training in the elderly. J Appl Physiol. 1990;69:1725-1733.
47. Frontera WR, Meredith CN, O'Reilly KP, Knuttgen HG, Evans WJ. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol. 1988;64:1038-1044.
48. Charette SL, McEvoy L, Pyka G, et al. Muscle hypertrophy response to resistance training in older women. J Appl Physiol. 1991;70:1912-1916.
49. Brandon LJ, Gaasch DA, Boyette LW, Lloyd AM. Effects of long-term resistive training of mobility and strength in older adults with diabetes. J Gerontol Med Sci. 2003;58:740-745.
50. Thomas VS, Hageman PA. Can neuromuscular strength and function in people with dementia be rehabilitated using resistance-exercise training: results from a preliminary intervention study. J Gerontol Med Sci. 2003;58A:746-751.
51. Adamopoulos S, Parissis J, Karatzas D, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol. 2002;39:653-663.
52. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels in aging men. J Gerontol Med Sci. 2002;57A: M76-M79.
53. Morley JE, Perry HM. Androgens and women at the menopause and beyond. J Gerontol Med Sci. 2003;58A:409-416.
54. Kenny AM, Dawson L, Leppinger A, Iannuzzi-Sucich M, Judge JO. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy. J Gerontol Med Sci. 2003;58A:436-440.
55. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol Med Sci. 2003;58A:618-625.
56. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol Med Sci. 2001;56: M266-M272.
57. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol Med Sci. 2002;57A:M772-M777.
58. Morley JE. Andropause: is it time for the geriatrician to treat it? J Gerontol Med Sci. 2001;56A:M263-M265.
59. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol Med Sci. 2003;58A:618-625.
60. Morley JE. The need for a men's health initiative. J Gerontol Med Sci. 2003;58:614-617.
61. Bhasin S. Testosterone supplementation for aging-associated sarcopenia. J Gerontol Med Sci. In press.
62. Morley JE, Kaiser FE, Sih R, Hajjar R, Perry HM. Testosterone and frailty. Clin Geriatr Med. 1997;13:685ff.
63. Perry HM, Miller DK, Patrick P, Morley JE. Testosterone and leptin in older African-American men: relationship to age, strength, function and season. Metab Clin Exper. 2000;49:1085-1091.
64. Karcic E, Philpot C, Morley JE. Treating malnutrition with megestrol acetate: Literature review and review of our experience. J Nutr Health Aging. 2002;6:191-200.
65. Yeh SS, Wu SY, Levine DM, et al. The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. J Gerontol Med Sci. 2001;56A:M48-M54.
66. Lambert CP, Sullivan DH, Evans WJ. Effects of testosterone replacement and/or resistance training on interleukin-6 tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. J Gerontol Med Sci. 2003;58A:165-170.